Objectives-Although pulmonary abnormalities are easily seen with standard echocardiography or pocket-sized ultrasound devices, we sought to observe the prevalence of lung ultrasound apical B-lines and pleural effusions and their associations with inpatient, 1-year, and 5-year mortality when found in hospitalized patients referred for echocardiography.
P ulmonary edema and pleural effusions are common manifestations of various mortal disease processes, [1] [2] [3] [4] [5] including heart failure, infection, embolism, and malignancy. Both pulmonary edema and pleural effusions have been related to all-cause mortality in previous studies that used physical examination or chest radiography: 2 techniques with variable and often poor diagnostic sensitivity. [6] [7] [8] [9] [10] [11] On ultrasound (US) imaging, interstitial abnormalities consistent with pulmonary congestion, inflammation, or fibrosis manifest as "ring-down" artifacts known as "B-lines" emanating from edematous or thickened tissue on or near the surface of the lung, [12] [13] [14] [15] [16] even in the absence of rales. 17 Similarly, US can show small amounts of pleural fluid, in contrast to physical examination 1, 3 or portable chest radiography, 8 which requires at least 200 mL to be present. Ultrasound's superior sensitivity for detecting extravascular lung water could alert the physician to the presence of critical disease when applied on admission, monitor responses to therapies during hospitalization, and help assess the readmission risk at discharge. 1, 3, 12, 18, 19 However, despite the immediate value of lung data, the pathways in which to obtain lung US study in the hospital have not been formalized.
Echocardiography is a frequently ordered initial test for the evaluation of suspected cardiopulmonary disease, and the same US transducer used in echocardiography can be used to detect pleural effusions or US B-lines [12] [13] [14] [15] 20 that form in the presence of interstitial lung edema. As few data exist regarding whether such lung findings have sufficient prevalence and prognostic importance in patients to warrant imaging during the initial echo study, we sought to review the outcomes of consecutive patients referred for echocardiography in which a 4-view US lung examination had been incorporated into the standard transthoracic echocardiogram. Our hypothesis was that the addition of 4 lung US views to an echocardiogram would provide important prognostic information in the evaluation of hospitalized patients with suspected cardiac disease.
Materials and Methods
The study was a retrospective cohort analysis approved by the Scripps Institutional Review Board (Scripps Health, San Diego, CA; number 13-6237). Data were obtained from consecutive inpatients referred for transthoracic echocardiographic examinations at a 300-bed tertiary care urban community hospital over a 3-month period. Echo examinations were standard clinical examinations conducted by registered sonographers using a cardiac transducer on a conventional full-featured echocardiographic system (S5-1MHz, iE33; Phillips Healthcare, Andover, MA). Repeated, follow-up, "limited," and stress (dobutamine or treadmill) studies were excluded. In addition to the standard echo imaging protocol as recommended by the American Society of Echocardiography, 21 a 4-view, 2-minute lung US examination was performed and recorded from each patient in the supine position to look for markers of interstitial pulmonary edema and pleural effusions. The lung examination consisted of the following: (1) sagittal views in the midclavicular line of the third intercostal space in both lung apices for a "comet-tail" artifact, 14, 15 defined as the presence of at least 3 vertical ring-down linear artifacts (B-lines) present in a single image in either lung (Figure 1 ) 3, 12, 13, 15, 16 ; and (2) coronal views in the posterior axillary line of the lateral costophrenic angle of both lung bases for pleural effusion, defined as an anechoic region of fluid between the lung and diaphragm in either hemithorax ( Figure  2) . 1, 3, 12 All sonographers were trained in performing this 4-view US lung examination, and proficiency was verified by both the echocardiography laboratory's physician director and chief sonographer (B.J.K. and J.N.P., respectively) before initiation of the study. To maintain the standard of echocardiographic imaging, the directional marker on pulmonary images was directed cephalad (Figures 1 and 2 ). This technique helped minimize the need to change protocols with the imaging transducer when transitioning from cardiac to pulmonary examinations.
All recorded lung examinations underwent a blinded review by an experienced echocardiographercardiologist familiar with lung US (B.J.K.) for the presence of at least 3 B-lines in the apical lung views and pleural effusions in the lung bases. Echocardiograms with technically inadequate pulmonary images were not included in the study. Any US apical lung image that was not framed between 2 rib shadows was thought to be a technically inadequate image, and the entire lung examination was disqualified from the study. When looking for pleural effusions at the bases, any image in which the proper 3 landmarks of the diaphragm, lung tissue (a moving pleural line or a solid echogenic region), and liver or spleen (depending on the side being imaged) were not identified was thought to be technically inadequate, and the entire lung examination was disqualified from inclusion in the study. A notable exception to this rule was in the case of very large pleural effusions, which prevent lung tissue from being seen during imaging, but all other landmarks could be identified. These lung examinations were included in the study, as they clearly showed positive findings for pleural effusions.
The presence of an impaired left ventricular ejection fraction (EF; <40%), as reported by the study's original interpreting cardiologist, was specifically sought from the study's final report in the electronic medical record to act as a recognized echo finding with which to compare prevalence and mortality rates in the study population.
An outcome assessment for each patient was conducted using hospital electronic medical records and the National Death Index database. Patients with invalid Social Security numbers or unconfirmed deaths were eliminated from the statistical analysis. Overall mortality was classified into 5 categories: in-hospital, postdischarge to 1-year, total 1-year, 1-to 5-year, and total 5-year periods. Data are presented as mean 6 standard deviation where applicable. Categorical variables are reported as percentages, and comparisons between groups were conducted by the v 2 test. The statistical analysis was conducted with R version 3.3.1 software (R Foundation for Statistical Computing, Vienna, Austria). Kaplan-Meier curves were generated and compared by a log rank test for the presence or absence of any lung findings. A multivariate Cox proportional hazard regression model was used to assess the association between pleural effusions, comet-tail artifacts, and the outcome of death during the study. Age and sex were examined as covariates. A subsequent model was explored in which the reported finding of a left ventricular EF of less than 40% was an additional covariate. Th proportional hazards assumption was tested in the Cox regression model. Hazard ratios (HRs) were estimated with 95% confidence intervals (CIs). Two-tailed P < .05 was considered significant.
Results
During the 3-month study period, 690 consecutive initial inpatient echocardiograms were examined, of which 507 (73%) had technically adequate pulmonary views and were included in the study. Of the 507 studies, 21 patient studies did not have an associated valid Social Security number and were eliminated. Of the remaining 486 studies that constituted the cohort, the mean patient age at the time of the initial echocardiogram was 68 6 17 years; the median age was 70 years (interquartile range, 27 years); and 51% of patients were male. Inhospital, total 1-year, and total 5-year overall mortality for the study population were 4.7% (23 deaths), 21.0% (104 deaths), and 41% (199 deaths), respectively. The prevalence of an abnormal lung finding among the 486 studies was 39% (n 5 191). By lung finding, 10% (n 5 49) were found to have isolated pleural effusions; 19% (n 5 93) were found to have isolated comettail artifacts (3 apical B-lines); and 10% (n 5 49) had both pleural effusions and comet-tail artifacts. In comparison, 12% (n 5 59) of the study population had a reported EF of less than 40%.
Of all 199 deaths by 5 years, 56.0% (n 5 107) involved patients with abnormal lung findings. KaplanMeier curves (Figure 3) show a significant association of abnormal lung findings with increased mortality (P < .0001). In the univariate analysis (Table 1) , patients with versus without any abnormal lung findings had higher in-hospital (8.9% versus 2.0%; P 5 .001), 1-year (33% versus 14%; P < .001); and 5-year (56% versus 31%; P < .001) mortality.
Patients with both abnormal lung findings had the highest mortality rates in the hospital (16%), at 1 year (49%), and at 5 years (71%). In comparison, the echo finding of an EF of less than 40% was associated with 12% in-hospital, 32% 1-year, and 54% 5-year mortality.
Cox regression showed an independent in-hospital mortality risk associated with the presence of the comet-tail artifact (HR, 4.3; 95% CI, 1.7-11.0) and pleural effusions (HR, 2.5; 95% CI, 1.1-6.0). This mortality association persisted in patients with pleural effusions who survived hospitalization up to 1 year (HR, 2.2; 95% CI, 1.4-3.5) and had less significance from 1 year to 5 years after hospitalization (HR, 1.6; 95% CI, 1.0-2.6). B-lines, on the other hand, were not found to have a statistically significant relationship with mortality beyond the index hospitalization (Table 2) , compatible with the hypothesis that apical B-lines are potentially indicative of a more serious acute process, whereas pleural effusions may signify the presence of a more chronic illness.
The variable of an EF of less than 40% when added into the multivariate analysis showed no significant independent effect on mortality and was removable without any significant change in the model's results, suggesting that the association of an EF of less than 40% with mortality may be better reflected in the presence of B-lines or effusions, such as in decompensated congestive heart failure. 
Discussion
This study evaluated the association of lung US findings with short-and long-term mortality when obtained from 4 lung views that had been incorporated into the standard echocardiogram. Lung findings were frequently present, with a 39% prevalence rate, and associated with increased in-hospital mortality and a continued mortality risk that persisted primarily through the initial year after hospitalization in this retrospective cohort analysis (Tables 1 and 2 ). The in-hospital mortality of 16%, and 1-year mortality of 49% support the notion that the combination of US lung findings may identify a high-risk group that may require medical attention in the critical first year after an index hospitalization.
Whether tabulated by an 8-zone or a more extensive 28-zone imaging method, the presence of the B-line artifact has been related to higher pulmonary capillary wedge pressures, brain natriuretic peptide levels, and New York Heart Association classes in patients with heart failure. 22, 23 B-lines have also been associated with hospitalization and death in prior smaller studies of specific patient populations with decompensated heart failure, 17, 24, 25 renal failure, 18 dyspnea and/or chest pain, 19 Figure 3. Kaplan-Meier mortality graph of abnormal lung findings versus no lung findings. Curves are significantly different (P <.0001). Hazard ratios (95% CIs) for the entire group (in-hospital, 1-year, and 5-year mortality) show significance in both abnormal lung findings. Interval hazard ratios (95% CIs) for 2 specific periods (postdischarge to 1-year and 1-to 5-year mortality) show the persistence of a significant mortal effect among survivors of the initial diagnostic finding of pleural effusions and age. a P <.05; b P <.01; c P <.001.
and acute coronary syndromes. 26 Recent studies have demonstrated the specific independent prognostic value of the B-line artifact. In a study of 118 patients admitted for acute heart failure, 27 only the finding of more than 15 B-lines at discharge predicted the outcome of heart failure readmission within 6 months, compared to known echo parameters such as the wall motion score index, restrictive mitral filling pattern, and pulmonary artery systolic pressures. Similarly, in a study of 60 patients admitted for heart failure, 28 a multivariable analysis found that the presence of an abnormal lung scan, defined as either a 30 or more total B-line count or a 1-zone-positive scan, and a NYHA III or higher outperformed echo parameters such as inferior vena cava diameter, E/e 0 ratio higher than 15, E/A ratio, and brain natriuretic peptide as factors in predicting the combined outcome of death or rehospitalization at 3 months. The comet-tail artifact, conventionally described for clinical expediency as a collection of 3 or more B-lines within a single view, has 80% to 90% specificity for apical interstitial disease or congestive heart failure when found at the transducer locations in this study, 10, 15, 29 which may account for the mortality effect associated with this particular finding.
Pleural effusion on US imaging has been previously reported as a marker of clinical worsening in patients with congestive heart failure, having sensitivity of 76.6% and specificity of 98.6%, which outperforms physical examination and chest radiography. 11 In studies of patients considered for thoracentesis, pleural effusions on chest radiography, whether caused by malignancy, congestive heart failure, renal disease, liver failure, infectious, multiple benign, and unknown etiologies were found to have high 30-day and 1-year mortality of 11% to 29% and 26% to 55%, respectively, 30,31 a wide range that was attributable to the etiology. Our findings indicate a high prevalence of 20% and a similarly high mortality risk of pleural effusions when found by US, either alone (4.1% inpatient and 33.0% 1-year mortality) or, even more ominous, in combination with B-lines (16% inpatient and 49% 1-year mortality). In a previously reported retrospective review of 251 consecutive echocardiograms with incidentally detected left pleural effusions during standard echo imaging, an association with high 1-year (range, 0%-47%) and 5-year (range, 22%-56%) mortality was noted, depending on the etiology of the effusion, and was particularly worse in patients with malignancy. 20 Our study used 2 dedicated posterobasal coronal views of both lungs specifically for detection of smaller amounts of pleural fluid by visualization of the diaphragm as a landmark 3, 12, 32 and found a similar association with mortality.
In this study, lung US abnormalities were as mortal as the finding of left ventricular systolic dysfunction on the echocardiogram and were greater than 3 times more frequently found (39% versus 12%). Despite these observations, most hospitals currently lack a clinical pathway in which to provide a lung US study. From a perspective of health care delivery, many patients with suspected cardiovascular disease are referred for echocardiography as an initial diagnostic test or, as practiced more recently in emergency medicine, may have received an initial US scan at the point of care. 12, 24 Lung imaging when performed during standard echocardiography requires essentially no additional resources and may provide complementary information to echocardiographic data and may clarify findings, 33 particularly in the patient with unexplained dyspnea.
As an imaging study, our study had several limitations, primarily due to its perspective from the echo laboratory of exploring the utility of additional lung views in its standard cardiac imaging protocol. In this inpatient population, sonographers were unable to obtain all 4 views in 27% of patients. This technical difficulty rate was likely an overestimate, as sonographers had only recently been trained on how to acquire these views, and a blinded study reader used strict, unbiased criteria for technical inadequacy. As the study was a retrospective analysis of consecutive inpatient echocardiograms, the many etiologies of the pleural effusions and B-lines were not determined, nor were the individual patient or echocardiographic factors (other than EF <40%), which could have been used for generating hypotheses regarding specific pathophysiologic mechanisms and outcomes. However, in standard practice, hospital echocardiograms and point-of-care US examinations in the acutely ill are usually interpreted in the setting of minimal data and provisional diagnoses known to the reader, often with only age and sex, as in this study. Similarly, the timing of when echocardiographic examinations were performed during a patient's hospitalization could affect the prevalence of evanescent imaging findings, such as B-lines. However, it is standard practice for our institution that all echocardiographic and lung US examinations are performed within 24 hours of being ordered. Our study population was relatively large, typical of an urban community hospital, and likely representative of inpatient medical practice, as evidenced by the similar mortality in our subgroup of patients with a reduced EF compared to other contemporary studies of heart failure with a low EF. 34, 35 Our study did not assess whether the lung examination affected the interpretation of the echo findings or specifically changed management.
In conclusion, the findings of US apical B-lines and pleural effusions during inpatient echocardiography are common and have a relationship with short-and longterm mortality. This study provides an evidence basis for incorporating lung imaging into the standard echocardiogram or point-of-care imaging of acutely ill patients in whom echocardiography has been ordered and has implications for formalizing access to lung US data in medical diagnostic testing.
